Acute myeloid leukemia in four patients with t(8;21) treated with all-trans retinoic acid as a single agent

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Leukemia and Lymphoma

• Publication date

  2008-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10428190801959018PMID 18464121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.

  2007cited by this paper
• Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.

  2007cited by this paper
• The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription

  2007cited by this paper
• Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia.

  2005cited by this paper
• Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

  2004cited by this paper
• Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?

  2001cited by this paper
• All trans retinoic acid in acute promyelocytic leukemia

  2001cited by this paper
• Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.

  2001cited by this paper
• Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.

  2000cited by this paper
• Effects of retinoids on cell toxicity and apoptosis in leukemic blast cells from patients with non-M3 AML.

  2000cited by this paper
• Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia

  1999cited by this paper
• Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

  1999cited by this paper
• ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors

  1998cited by this paper
• All-trans-retinoic acid in acute promyelocytic leukemia.

  1997cited by this paper
• Oncogenic transcription factors in the human acute leukemias.

  1997cited by this paper
• AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia.

  1995cited by this paper

• All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16

  2021cites this paper
• Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces 18F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosis

  2020cites this paper
• Acute myeloid leukemia in an 86-year-old man with AML1/ETO treated with Homoharringtonine and Arsenic Trioxide

  2019cites this paper
• The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients

  2019cites this paper
• Post-translational modification of retinoic acid receptor alpha and its roles in tumor cell differentiation.

  2019cites this paper
• A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia

  2018influential citation
• Potential role for all-trans retinoic acid in nonpromyelocytic acute myeloid leukemia.

  2016cites this paper
• An ATRActive future for differentiation therapy in AML.

  2015cites this paper
• Co-expression of t(15;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature

  2013cites this paper
• Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case Study

  2010cites this paper